Position | Company | Period |
---|
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-01 | 2024-03-01 |
Protagonist Therapeutics Inc
(PTGX)
|
PS Planned sale |
12,975
-52.0%
31.34406,637 USD |
12,975 -52.0% | 31.34 | 406,637 USD | |
2024-01-16 | 2024-01-11 | PS Planned sale |
1,300
-2.6%
38.5950,167 USD |
1,300 -2.6% | 38.59 | 50,167 USD | ||
2024-01-16 | 2024-01-11 | PS Planned sale |
2,634
-5.1%
37.8199,592 USD |
2,634 -5.1% | 37.81 | 99,592 USD | ||
2023-01-11 | 2023-01-09 | PS Planned sale |
3,200
-10.0%
30.0096,000 USD |
3,200 -10.0% | 30.00 | 96,000 USD | ||
2022-01-04 | 2022-01-03 | PS Planned sale |
272
-1.0%
66.2518,020 USD |
272 -1.0% | 66.25 | 18,020 USD | ||
2022-01-04 | 2022-01-03 | PS Planned sale |
2,128
-7.6%
65.01138,341 USD |
2,128 -7.6% | 65.01 | 138,341 USD | ||
2022-01-04 | 2022-01-03 | PS Planned sale |
2,100
-6.9%
64.23134,883 USD |
2,100 -6.9% | 64.23 | 134,883 USD | ||
2021-01-05 | 2021-01-04 | S Sale |
3,750
-11.0%
76.08285,300 USD |
3,750 -11.0% | 76.08 | 285,300 USD | ||
2020-12-11 | 2020-12-10 | S Sale |
1,800
-6.7%
73.10131,580 USD |
1,800 -6.7% | 73.10 | 131,580 USD | ||
2020-12-11 | 2020-12-10 | S Sale |
1,200
-4.3%
68.5082,200 USD |
1,200 -4.3% | 68.50 | 82,200 USD | ||
2020-05-13 | 2020-05-11 | S Sale |
26,000
-48.1%
36.54950,040 USD |
26,000 -48.1% | 36.54 | 950,040 USD | ||
2019-01-11 | 2019-01-11 | S Sale |
8,500
-15.5%
14.77125,545 USD |
8,500 -15.5% | 14.77 | 125,545 USD |